natgillin/translations-raw huggingface dataset:
Children before puberty, who suffer from long-term kidney problems
Otroci pred puberteto, z dolgotrajnimi težavami z ledvicami
Children below 2 years of age
Otroci, mlajši od 2 let
Children below 6 months of age:
Otroci, mlajši od 6 mesecev:
Children below 6 months of age:
Otroci, stari manj kot 6 mesecev:
Children below the age of 3 years
Otroci, mlajši od 3 let
children between 12 and 23 months of age should receive two doses with an interval of at least two months; children between two and 17 years of age should receive a single dose.
otroci, stari od 12 do 23 mesecev, morajo prejeti dva odmerka, med katerima mora biti vsaj dvomesečni presledek; otroci, stari od dve leti do 17 let, morajo prejeti enojni odmerek.
Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the RSV season
pri otrocih, ki so se rodili z največ 35 gestacijskimi tedni in so na začetku sezone RSV mlajši od 6 mesecev,
Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the RSV season.
pri otrocih, ki so se rodili z največ 35 gestacijskimi tedni in so na začetku sezone RSV mlajši od 6 mesecev,
Children born smaller or lighter than expected and with growth disturbance:
Otroci, ki so se rodili manjši ali lažji od pričakovanega in z motnjami v rasti:
Children can take the adult dose of one 700 mg Telzir tablet twice daily (with ritonavir 100 mg twice daily) if they weigh at least 39 kg and can swallow the tablets whole.
Otroci lahko dobijo odmerek za odrasle - eno 700 mg tableto zdravila Telzir dvakrat na dan (in 100 mg ritonavirja dvakrat na dan) - če tehtajo vsaj 39 kg in lahko tablete pogoltnejo cele.
Children can take the adult tablet dose of one 700 mg Telzir tablet twice daily with ritonavir 100 mg twice daily if they can swallow the tablets whole.
Otroci lahko dobijo odmerek za odrasle - eno 700 mg tableto zdravila Telzir dvakrat na dan in 100 mg ritonavirja dvakrat na dan - če lahko tablete pogoltnejo cele.
Children do not develop multiple myeloma.
Multipli mielom se ne pojavlja pri otrocih.
Children four years of age or older weighing less than 30 kg (taking valproate)
Otroci, stari štiri leta ali več, s telesno maso manjšo od 30 kg (ki jemljejo valproat)
Children from 14 months to < 3 years of age should receive a single 0.25 ml booster dose.
Otroci, stari od 14 mesecev do < 3 let, naj bi prejeli enkratni obnovitveni odmerek 0,25 ml.
Children from 2 months to < 3 years of age
Otroci, stari od 2 mesecev do < 3 leta starosti
Children from 2 to 12 years of age
Otroci, stari od 2 do 12 let
Children from 3 years of age, adolescents and adults up to 60 years of age: One dose of 0.5 ml at an elected date.
Otroci, starejši od 3 let, mladostniki in odrasli do 60 let starosti: En 0,5-ml odmerek na izbrani datum.
Children from 3 years of age, adolescents and adults up to 60 years of age: One dose of 0.5 ml of the vaccine will be given.
Otroci od 3 let starosti, odraščajoči in odrasli do 60 let starosti: Dobili boste en 0,5-ml odmerek cepiva.
Children from 4 years and adolescents weighing less than 50 kg
Otroci od 4. leta in mladostniki s telesno maso manj kot 50 kg
Children from 4 years and adolescents weighing less than 50 kg
Otroci, starejši od 4 let, in mladostniki, s telesno maso manj kot 50 kg
Children from 6 months of age to less than 3 years of age: One half-dose of 0.25 ml at an elected date.
Otroci, starejši od 6 mesecev in mlajši od 3 let: En polovični 0,25-ml odmerek na izbrani datum.
Children from 6 months to 9 years of age
Otroci, stari od 6 mesecev do 9 let
Children from 6 to 11 years of age
Uporaba pri otrocih, starih od 6 do 11 let
children from 6 to less than 12 years should receive an additional 10 mg/kg/day each week, thus achieving the recommended dose of 50 mg/kg/day in four weeks; children and adolescents 12 years and older should receive an additional 5 mg/kg/day each week until the optimum dose is reached based on clinical judgment.
otroci, stari 6 do 12 let, vsak teden prejmejo dodatnih 10 mg/kg/dan, tako da začnejo prejemati priporočen odmerek 50 mg/kg/dan v štirih tednih; otroci in mladostniki, stari 12 let in več, vsak teden prejmejo dodatnih 5 mg/kg/dan, dokler ne dosežejo odmerka, najprimernejšega po klinični presoji.
children from 6 weeks to 17 years to help protect against diseases such as: meningitis (inflammation around the brain), sepsis or bacteraemia (bacteria in the blood stream), pneumonia (lung infection) and ear infections
otrok, starih od 6 tednov do 17 let, za zaščito pred boleznimi, kot so: meningitis (vnetje možganskih ovojnic), sepsa ali bakteriemija (prisotnost bakterij v krvi), pljučnica (okužba pljuč) in okužbe ušesa;
Children from 6 years of age and weighing at least 39 kg
Otroci od 6. leta starosti in s telesno maso vsaj 39 kg
Children from 6 years of age and weighing less than 39 kg
Otroci od 6. leta starosti in s telesno maso manj kot 39 kg
Children from one year of age: The recommended dose is 4 mg/kg twice daily, or 8 mg/kg once daily up to a maximum total daily dose of 300 mg (30 ml).
Otroci, od enega leta starosti : Priporočen odmerek je 4 mg/kg dvakrat na dan ali 8 mg/kg enkrat na dan do najvišjega celotnega dnevnega odmerka 300 mg (30 ml).
Children from the age of 3 to 11 must take the contents of 1 jar with 45 mg.
Otroci, stari od 3 - 11 let, vzamejo vsebino 1 lončka s 45 mg.
Children from three months of age: As an accurate dosage cannot be achieved with the 300 mg non- scored tablet formulation in this patient population, it is recommended that the Epivir 150 mg scored tablet formulation is used and the corresponding recommended dosage instructions are followed.
Otroci, starejši od treh mesecev: Ker pri tej populaciji bolnikov ne moremo zagotoviti točnega odmerka s 300 mg tableto brez razdelilne zareze, je priporočljiva uporaba zdravila Epivir 150 mg tablete z razdelilno zarezo, pri čemer je potrebno slediti ustreznim priporočilom odmerjanja.
Children from three months to one year of age: The recommended dose is 4 mg/kg twice daily.
Otroci, od treh mesecev do enega leta starosti: Priporočen odmerek je 4 mg/kg dvakrat na dan.
children from two years of age and adolescents who fail to grow because they lack growth hormone (replacement therapy); children who are short because of Turner syndrome (a rare genetic disorder affecting girls), confirmed by chromosome analysis (DNA testing); children before puberty, who fail to grow because of longstanding kidney disease (chronic renal insufficiency).
otrok, starih vsaj dve leti, in mladostnikov z motnjami v rasti zaradi pomanjkanja rastnega hormona (nadomestna terapija); otrok, ki so premajhne rasti zaradi Turnerjevega sindroma (redka prirojena bolezen, ki prizadene dekleta), potrjenega s kromosomsko analizo (analiza DNK); otrok pred puberteto z zastojem v rasti zaradi dolgotrajne bolezni ledvic (kronično ledvično obolenje).
Children generally have lower clearance of rufinamide than adults, and this difference is related to body size.
Otroci imajo na splošno manjši očistek rufinamida kot odrasli, ta razlika pa je povezana z velikostjo telesa.
Children given emtricitabine also experienced changes in skin colour including darkening of the skin in patches, very commonly and anaemia (low red blood cell count), commonly.
Pri otrocih, ki so prejemali emtricitabin, je bila zelo pogosta tudi sprememba obarvanosti koţe, vključujoč temne lise in pogosta anemija (nizko število rdečih krvnih telesc).
Children in this study demonstrated ACR Ped 30, 50, 70, and 90 responses as early as week 4.
V tej študiji so otroci že v 4. tednu pokazali odzive ACR Ped 30, 50, 70 in 90.
Children less than 12 months of age
Otroci, mlajši od 12 mesecev
Children less than 12 months of age should not receive this vaccine because of the risk of side effects. if you have had any allergic reaction other than a sudden life-threatening allergic reaction to eggs, egg proteins, gentamicin, or gelatin or any of the other ingredients of this vaccine (listed in section 6 “Contents of the pack and other information”). if you are already taking acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever).
Otroci, mlajši od 12 mesecev, zaradi tveganja za neželene učinke ne smejo dobiti tega cepiva. če ste kdaj imeli kakršno koli alergijsko reakcijo (razen nenadne, smrtno nevarne alergijske reakcije) na jajca, jajčne beljakovine, gentamicin ali želatino, ali na katero koli sestavino tega cepiva (navedeno v poglavju 6, "Vsebina pakiranja in dodatne informacije"). če že jemljete acetilsalicilno kislino (zdravilno učinkovino, ki jo vsebujejo številna zdravila proti bolečinam in zdravila za zniževanje visoke telesne temperature).
Children less than 2 years
Otroci, mlajši od 2 let
Children less than 2 years of age
Otroci, mlajši od 2 let
Children less than 4 years of age: Agenerase oral solution is contraindicated in children less than 4 years of age. (see sections 4.3 and 5.3 ).
Otroci, mlajši od 4 let: Peroralna raztopina Agenerase je kontraindicirana pri otrocih, mlajših od 4 let (glejte poglavji 4.3 in 5.3).
children less than 6 years should receive an additional 20 mg/kg/day in the third week, thus achieving the recommended dose of 50 mg/kg/day in three weeks;
otroci, mlajši od 6 let, tretji teden prejmejo dodatnih 20 mg/kg/dan, tako da začnejo prejemati priporočen odmerek 50 mg/kg/dan v treh tednih;
Children less than three months of age: The limited data available are insufficient to propose specific dosage recommendations (see section 5.2).
Otroci, mlajši od 3 mesecev: Skopi podatki, ki so na voljo, ne zadoščajo, da bi podali posebna priporočila glede odmerjanja (glejte poglavje 5.2).
Children less than three years old
Otroci, mlajši od 3 let
Children less than three years old.
Otroci, mlajši od treh let
Children must not come into contact with the veterinary medicinal product.
Otroci ne smejo priti v stik s tem zdravilom za uporabo v veterinarski medicini.
Children must not come into contact with Trifexis.
Preprečite stik otrok z zdravilom Trifexis.
Children must not handle treated dogs for at least four hours after administration of the veterinary medicinal product.
Otroci naj se ne igrajo z zdravljenimi živalmi vsaj štiri ure po nanosu zdravila za uporabo v veterinarski medicini.
Children must not handle treated dogs for at least four hours after administration of the veterinary medicine.
Otroci naj se ne igrajo z zdravljenimi živalmi vsaj štiri ure po nanosu zdravila za uporabo v veterinarski medicini.
Children not vaccinated according to recommended schedule
Otroci, ki niso bili cepljeni po priporočeni shemi
Children of 2 to 6 years of age: The primary vaccination is 3 doses taken orally (by mouth) at least 1 week (up to 6 weeks) apart.
Otroci, stari od 2 do 6 let: Primarno cepljenje obsega 3 odmerke, ki se vzamejo peroralno (skozi usta) s presledkom najmanj 1 tedna (do 6 tednov).
Children or adolescents under 18 years
Otroci ali mladostniki, mlajši od 18 let
Children or adolescents with psoriasis
Otroci ali mladostniki z luskavico
Children over the age of 14 days receive 1 mg per kilogram body weight, unless they weigh more than 30 kg.
Otroci, starejši od 14 dni, prejmejo 1 mg na kilogram telesne mase, razen če tehtajo več kot 30 kg.
Children receiving abacavir oral tablets according to the recommended dosage regimen achieve higher plasma abacavir exposure than children receiving oral solution because higher mg/kg doses are administered with the tablet formulation.
Otroci, ki prejemajo abakavir v obliki peroralnih tablet po priporočenem režimu odmerjanja, dosežejo višjo izpostavljenost abakavirju v plazmi kot otroci, ki prejemajo peroralno raztopino; v obliki tablet se namreč dajejo večji odmerki (v mg/kg).
Children should keep scheduled doctor’s visits because their Isentress dosage should be adjusted as they get older, grow or gain weight.
Otroka morate redno voditi na preglede k zdravniku, saj je odmerek zdravila Isentress treba prilagajati glede na otrokovo starost, rast ali telesno maso.
Children should not come in contact with Palladia.
Otroci ne smejo priti v stik s Palladia-o.
Children should not take Irbesartan BMS
Otroci ne smejo jemati zdravila Irbesartan BMS
Children should not take Irbesartan Hydrochlorothiazide BMS
Otroci ne smejo jemati zdravila Irbesartan Hydrochlorothiazide BMS
Children should not take Irbesartan Hydrochlorothiazide Zentiva
Otroci ne smejo jemati zdravila Irbesartan Hydrochlorothiazide Zentiva
Children should not touch the dog before:
Otroci se lahko dotikajo psa od:
Children should receive recommended vaccinations before starting Flixabi treatment.
Otroci morajo prejeti priporočena cepljenja, preden se začnejo zdraviti z zdravilom Flixabi.
Children should receive recommended vaccinations before starting Inflectra treatment.
Otroci morajo prejeti priporočena cepljenja, preden se začnejo zdraviti z zdravilom Inflectra.
Children should receive recommended vaccinations before starting Remicade treatment.
Otroci morajo prejeti priporočena cepljenja, preden se začnejo zdraviti z zdravilom Remicade.
Children should receive recommended vaccinations before starting Remsima treatment.
Otroci morajo prejeti priporočena cepljenja, preden se začnejo zdraviti z zdravilom Remsima.
Children taking Combivir should be closely monitored for side effects.
Otroke, ki jemljejo zdravilo Combivir, je treba skrbno nadzorovati glede pojava neželenih učinkov.
Children three years and older and adolescents
Otroci, starejši od treh let in mladostniki
Children treated with Unituxin will first have responded to chemotherapy and then received an additional treatment to clear out their bone marrow (myeloablative therapy) and a stem- cell transplantation.
Otroci, zdravljeni z zdravilom Unituxin, se morajo najprej odzvati na kemoterapijo, potem pa prestati dodatno zdravljenje za prečiščenje kostnega mozga (mieloablacijsko terapijo) in presaditev matičnih celic.
Children under 10 years of age should take 100 mg per kilogram of body weight a day, divided into two equal doses.
Otroci, mlajši od 10 let, naj prejemajo 100 mg na kg telesne mase dnevno, razdeljenih v dva enaka odmerka.
Children under 12 years of age should also have the procedure if they have unexplained blood in their stool.
Otrokom, mlajšim od 12 let, je treba ta postopek narediti tudi, če imajo nepojasnjeno kri v blatu.
children under 16 years of age who:
otroci, mlajši od 16 let , ki :
children under 16 years of age who:
otroci, mlajši od 16 let , ki:
children under 16 years of age who:
otroci, mlajši od 16 let, ki:
Children under 18 years
Otroci, mlajši od 18 let
Children under the age of 18 must not take Cinacalcet Mylan.
Zdravila Cinakalcet Mylan ne smejo jemati otroci, mlajši od 18 let.
Children under the age of 18 must not take Mimpara.
Zdravila Mimpara ne smejo jemati otroci, mlajši od 18 let.
Children under two years old also receive an additional booster dose (at a time point determined by age).
Otroci do drugega leta starosti prejmejo tudi dodaten poživitveni odmerek (čas za to cepljenje je določen glede na starost).
Children weighing
Pri otrocih, ki tehtajo manj
Children weighing 75 kg or more should be administered ORENCIA following the adult dosing regimen.
Otroci s telesno maso 75 kg ali večjo, morajo zdravilo ORENCIA prejeti v skladu z režimom odmerjanja za odrasle.
Children weighing > 40 kg and who are able to swallow capsules may receive prophylaxis with a 75 mg capsule once daily for 10 days as an alternative to the recommended dose of Tamiflu suspension.
Otroci, ki tehtajo več kot 40 kg in in zmorejo pogoltniti kapsulo, lahko za preprečevanje gripe namesto priporočenega odmerka suspenzije zdravila Tamiflu prejmejo 75-mg kapsule enkrat na dan 10 dni.
Children weighing > 40 kg and who are able to swallow capsules may receive treatment with the adult dosage of 75 mg capsules twice daily for 5 days as an alternative to the recommended dose of Tamiflu suspension.
Otroci, ki tehtajo več kot 40 kg in zmorejo pogoltniti kapsulo, lahko namesto priporočenega odmerka suspenzije zdravila Tamiflu prejmejo odmerek za odrasle – 75-mg kapsulo dvakrat na dan 5 dni.
Children weighing > 50 kg received 2 mg/day Resolor tablets or matching placebo.
Otroci s telesno maso > 50 kg so dobivali odmerek 2 mg/dan v obliki tablet zdravila Resolor ali ustrezni placebo.
Children weighing at least 14 kg and less than 20 kg
Deti s telesnou hmotnosťou aspoň 14 kg a nižšou ako 20 kg:
Children weighing at least 14 kg and less than 20 kg: The usual dose of Ziagen is 300 mg a day.
Otroci, ki tehtajo vsaj 14 kg in manj kot 20 kg: Običajni odmerek zdravila Ziagen je 300 mg na dan.
Children weighing at least 20 kg and less than 25 kg
Deti s telesnou hmotnosťou aspoň 20 kg a nižšou ako 25 kg:
Children weighing at least 20 kg and less than 25 kg: The usual dose of Ziagen is 450 mg a day.
Otroci, ki tehtajo vsaj 20 kg in manj kot 25 kg: Običajni odmerek zdravila Ziagen je 450 mg na dan.
Children weighing between 21 kg and 30 kg: the recommended oral dose of Lamivudine/Zidovudine Teva is one-half tablet taken in the morning and one whole tablet taken in the evening.
Otroci s telesno maso od 21 kg do 30 kg: Priporočeni peroralni odmerek zdravila Lamivudin/zidovudin Teva je polovica tablete zjutraj in ena cela tableta zvečer.
Children weighing from 14 kg to 21 kg: the recommended oral dose of Lamivudine/Zidovudine Teva is one-half tablet taken twice daily.
Otroci s telesno maso od 14 kg do 21 kg: Priporočeni peroralni odmerek zdravila Lamivudin/zidovudin Teva je polovica tablete dvakrat na dan.
Children were eligible when they were aged <18 years, ≥15 kg in weight, receiving cART that included lopinavir/ritonavir, HIV-1 ribonucleic acid (RNA) <50 copies/ml for at least 24 weeks and able to swallow tablets.
Vključitveni kriteriji za otroke so bili: starost < 18 let, telesna masa ≥ 15 kg, ki so prejemali CART, ki je vključevala lopinavir/ritonavir, HIV-1 ribonukleinsko kislino (RNA) < 50 kopij/ml, najmanj 24 tednov, otroci pa so tablete lahko pogoltnili cele.
children who are less than six months old and were born five or more weeks prematurely (at 35 weeks gestation or less);
pri otrocih, mlajših od šest mesecev, ki so se rodili pet ali več tednov prezgodaj (s 35 tedni gestacijske starosti ali manj);
children who are less than two years of age and have had treatment for bronchopulmonary dysplasia (abnormal lung tissue, usually seen in babies born prematurely) within the last six months; children who are less than two years of age and were born with a serious heart disease.
pri otrocih, mlajših od dveh let, ki so se v zadnjih šestih mesecih zdravili zaradi bronhopulmonalne displazije (nenormalnega pljučnega tkiva, ki se navadno pojavi pri prezgodaj rojenih otrocih); pri otrocih, mlajših od dveh let, ki so se rodili s hudo boleznijo srca.
Children who are more likely to get severe RSV disease (high risk children) include babies born prematurely (35 weeks or less) or babies born with certain heart or lung problems.
Otroci, pri katerih je večja verjetnost, da bodo dobili resno okužbo z RSV (npr.: otroci z velikim tveganjem) so nedonošenčki (stari 35 tednov ali manj) ali dojenčki, rojeni z nekaterimi srčnimi in pljučnimi težavami.
Children who are more likely to get severe RSV disease (high-risk children) include babies born prematurely (35 weeks or less) or babies born with certain heart or lung problems.
Otroci, pri katerih je večja verjetnost, da bodo dobili resno okužbo z RSV (npr: otroci z velikim tveganjem) so nedonošenčki (stari 35 tednov ali manj) ali dojenčki, rojeni z nekaterimi srčnimi in pljučnimi težavami.
children who fail to grow because of a lack of growth hormone; girls from 2 years old who are short because of Turner syndrome (a rare genetic disorder affecting girls), confirmed by chromosome analysis (DNA testing); children (before puberty) who fail to grow because of long-lasting kidney disease, up to the time when they receive a kidney transplant.
otrok z motnjami v rasti zaradi pomanjkanja rastnega hormona; deklic po 2. letu starosti, ki so premajhne rasti zaradi Turnerjevega sindroma (redke genske okvare, ki prizadene dekleta), ki je bil potrjen s kromosomsko analizo (analizo DNK); otrok (pred puberteto), ki zaradi kronične odpovedi ledvic zaostajajo v rasti, do presaditve ledvice.
Children who received 2 doses of ProQuad intramuscularly or subcutaneously
Otroci, ki so prejeli 2 odmerka cepiva ProQuad intramuskularno ali subkutano
Children who received a second dose of ProQuad
Otroci, ki so bili cepljeni z drugim odmerkom cepiva ProQuad
Children who received a second dose of ProQuad
Otroci, ki so dobili drugi odmerek cepiva ProQuad
Children who received ProQuad intramuscularly
Otroci, ki so cepivo ProQuad prejeli intramuskularno
Children who took infliximab for Crohn’s disease showed some differences in side effects compared with adults who took infliximab for Crohn's disease.
Neželeni učinki pri otrocih in odraslih, ki so prejemali infliksimab za zdravljenje Crohnove bolezni, so se nekoliko razlikovali.
Children who took Remicade for Crohn’s disease showed some differences in side effects compared with adults who took Remicade for Crohn's disease.
Neželeni učinki pri otrocih in odraslih, ki so prejemali zdravilo Remicade za zdravljenje Crohnove bolezni, so se nekoliko razlikovali.
Children who weigh between 21 and 30 kg
Otroci, ki so težki od 21 – 30 kg
Children with a body surface area <0.6 m² should receive 82.5 U (equivalent to 0.1 ml Oncaspar)/kg body weight every 14 days.
Otroci s telesno površino < 0,6 m² morajo prejeti 82,5 e. (kar ustreza 0,1 ml zdravila Oncaspar)/kg telesne mase vsakih 14 dni.
Children with a weakened immune system (such as due to HIV infection or immunosuppressive therapy) may not get the full benefit from Synflorix.
Zgodi se lahko, da otrokom z oslabelim imunskim sistemom (npr. zaradi okužbe s HIV ali imunosupresivne terapije) cepivo Synflorix ne koristi v polni meri.
Children with chronic renal (kidney) insufficiency:
Otroci s kronično renalno (ledvično) insuficienco:
Children with growth failure associated with chronic renal insufficiency (n=171)
Otroci z zaostankom v rasti, povezanim s kronično insuficienco ledvic (n=171)
Children with growth failure due to inadequate growth hormone secretion (n=236)
Otroci z zaostankom v rasti zaradi nezadostnega izločanja rastnega hormona (n=236)
Children with growth hormone deficiency:
Otroci s pomanjkanjem rastnega hormona:
Children with hepatitis C are generally given 65 to 180 micrograms once a week, according to their height and weight, for 24 or 48 weeks depending on the type of hepatitis C virus.
180 mikrogramov enkrat na teden, odvisno od njihove telesne višine in mase, in sicer 24 ali 48 tednov glede na vrsto virusa hepatitisa C.
Children with impaired immune responsiveness, whether due to the use of immunosuppressive therapy, a genetic defect, HIV infection, or other causes, may have reduced antibody response to active immunisation.
Otroci z okvarjenim imunskim sistemom zaradi imunosupresivnega zdravljenja, genetskega defekta, okužbe s HIV ali drugih razlogov lahko slabše tvorijo protitelesa po aktivni imunizaciji.
Children with impaired immune responsiveness, whether due to the use of immunosuppressive therapy, a genetic defect, HIV infection, or other causes, may have reduced antibody response to vaccination.
Otroci z oslabljeno imunsko odzivnostjo (naj bo zaradi uporabe imunosupresivnih zdravil, genetske motnje, okužbe s HIV ali drugih vzrokov) se lahko slabše odzovejo na aktivno imunizacijo.
Children with pJIA ( aged 2 and over)
Otroci s pJIA (stari 2 leti ali več)
Children with polyarticular juvenile idiopathic arthritis
Otroci s poliartikularnim juvenilnim idiopatskim artritisom
Children with sJIA
Otroci s sJIA
Children with Turner syndrome:
Otroci s Turnerjevim sindromom:
Children with weights between 10.5–12 kg, 12–14 kg and 18–22 kg will receive a different number of tablets with each meal.
Otroci s telesno maso 10,5-12 kg, 12- 14 kg in 18–22 kg bodo ob vsakem obroku prejeli različno število tablet.
Children younger than 2 years old should receive the appropriate-for-age Synflorix vaccination series (see section 4.2).
Otroci, mlajši od 2 let, morajo dobiti svoji starosti ustrezno zaporedje cepljenja s cepivom Synflorix (glejte poglavje 4.2).